Biology decoded,
disease undone
Modulating transcription factor activity to restore health
Drug discovery is coming from the wrong direction: targeting the downstream consequences of disease rather than the underlying biological causes.
It’s time to flip the script.
By focusing on understanding and manipulating the master controllers of biology, we’re searching for drugs with the potential not just to delay disease progression, but to halt or even reverse it.
Flipping the script on drug discovery
Scripta is exploiting the unique information-rich properties of transcription factors to turn drug discovery on its head.
Built on best-in-class AI/ML models, our unbiased approach can be applied to any disease, revealing novel therapeutics with the potential to deliver transformative outcomes.
We start with genome-wide mapping of the transcription factors defining and driving disease. Next, we identify and predict molecules and targets that modulate them.
Finally, we close the loop by validating the results in our pre-mapped, patient-derived models.
Our first focus is finding therapies that truly change the course of neurodegenerative diseases such as Alzheimer’s, Parkinson’s and ALS.
Scientific leadership
We’re a dedicated team combining pharma, biotech and disease biology expertise with the computational power to push the boundaries of biology and deliver on our goal: disease modifying therapeutics that will make a real difference to patients.
Our board
We're proud to be backed by a phenomenal consortium of VCs, all of whom are represented on our Board with either Board members or observers.
Investors:
Latest news:
Insights
Subscribe to our Substack today and join a community exploring the cutting edge of this transformative science.